Perbak Capital Partners LLP is an institution, managing $568.0M across 288 long positions as of Q3 2025 with 51% ETF concentration.
Largest long holdings in Perbak Capital Partners LLP's portfolio (49.7% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
ETF ETF | $69.0M | 12.14% | +$33.3M Bought | — 447.2K shares | |
ETF ETF | $54.9M | 9.67% | -$988.1K Sold | — 289.6K shares | |
ETF ETF | $42.4M | 7.47% | +$21.9M Bought | — 541.5K shares | |
ETF ETF | $34.7M | 6.10% | +$10.2M Bought | — 52.0K shares | |
ETF ETF | $24.1M | 4.25% | +$7.8M Bought | — 173.4K shares | |
ETF ETF | $16.1M | 2.84% | +$5.1M Bought | — 66.6K shares | |
ETF ETF | $11.3M | 1.99% | +$11.3M New | — 190.1K shares | |
ETF ETF | $10.1M | 1.78% | +$10.1M New | — 35.8K shares | |
Drug Manufacturers - Specialty & Generic Healthcare | $10.0M | 1.75% | +$4.3M Bought | 0.10% 494.4K shares | |
ETF ETF | $9.9M | 1.75% | +$9.9M New | — 36.7K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Perbak Capital Partners LLP's latest filing
| Position | Shares Δ |
|---|---|
New | |
New | |
New | |
New | |
New |
| Position | Shares Δ |
|---|---|
Sold | |
Sold | |
Sold | |
Sold | |
Sold |
Portfolio insights and performance metrics for Perbak Capital Partners LLP
No concentration data available
We use cookies for analytics. See our Privacy and Cookie Policy.